Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyunil Ha

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Biochemical Pharmacology|April 15, 2004
Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza BungeHong-Hee Kim, Jung Ha Kim, Han Bok Kwak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-betaHyunil Ha, Jong-Ho Lee, Ha-Neui Kim, et al.
Blood|December 9, 2004
Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migrationHan Bok Kwak, Soo Woong Lee, Hye Mi Jin, et al.
Arthritis and Rheumatism|April 29, 2008
Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritisHan Bok Kwak, Hyunil Ha, Ha-Neui Kim, et al.
Bone Research|May 14, 2024
RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclastsMinhee Kim, Jin Hee Park, Miyeon Go, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2012
5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1Jung-Min Lee, Hyojung Park, A Long Sae Mi Noh, et al.
Biological & Pharmaceutical Bulletin|January 6, 2009
Pyridone 6, a pan-Janus-activated kinase inhibitor, suppresses osteoclast formation and bone resorption through down-regulation of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand (RANKL)-induced c-Fos and nuclear factor of activated T cells (NFAT) c1 expressionHan Bok Kwak, Hun Soo Kim, Myeung Su Lee, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Biochemical Pharmacology|April 15, 2004
Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza BungeHong-Hee Kim, Jung Ha Kim, Han Bok Kwak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-betaHyunil Ha, Jong-Ho Lee, Ha-Neui Kim, et al.
Blood|December 9, 2004
Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migrationHan Bok Kwak, Soo Woong Lee, Hye Mi Jin, et al.
Arthritis and Rheumatism|April 29, 2008
Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritisHan Bok Kwak, Hyunil Ha, Ha-Neui Kim, et al.
Bone Research|May 14, 2024
RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclastsMinhee Kim, Jin Hee Park, Miyeon Go, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2012
5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1Jung-Min Lee, Hyojung Park, A Long Sae Mi Noh, et al.
Biological & Pharmaceutical Bulletin|January 6, 2009
Pyridone 6, a pan-Janus-activated kinase inhibitor, suppresses osteoclast formation and bone resorption through down-regulation of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand (RANKL)-induced c-Fos and nuclear factor of activated T cells (NFAT) c1 expressionHan Bok Kwak, Hun Soo Kim, Myeung Su Lee, et al.
Pageof 9